Investors Should Take Note Of Takeda Pharmaceutical Co ADR (TAK)
Takeda Pharmaceutical Co ADR (TAK) concluded trading on Wednesday at a closing price of $13.29, with 3.78 million shares of worth about $50.22 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.76% during that period and on November 20, 2024 the price saw […]
Look For Institutional Buying In Takeda Pharmaceutical Co ADR (NYSE: TAK)
Takeda Pharmaceutical Co ADR (TAK) concluded trading on Thursday at a closing price of $14.58, with 5.77 million shares of worth about $84.12 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.32% during that period and on September 25, 2024 the price saw […]
Takeda Pharmaceutical Co ADR (NYSE: TAK): Analyst View Points To Future Growth
Takeda Pharmaceutical Co ADR (TAK) concluded trading on Thursday at a closing price of $14.38, with 3.5 million shares of worth about $50.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.89% during that period and on Thursday, February 01 price saw a […]
Takeda Pharmaceutical Co ADR (NYSE: TAK): Reassessing Prospects
Takeda Pharmaceutical Co ADR (TAK) concluded trading on 01/11/24 at a closing price of $14.93, with 2.95 million shares of worth about $43.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.42% during that period and on Thursday the price saw a gain […]
Better Times Ahead For Takeda Pharmaceutical Co ADR (NYSE: TAK)?
Capital Research & Management Co has recently announced that it has increased stake in Takeda Pharmaceutical Co ADR (NYSE:TAK) by 0.05%. After grabbing 13.79 million shares, the institutional investor is now in possession of 6518.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.44% having worth around $195.19 […]
